Drug Profile
Research programme: mesenchymal stem cells - Morphogen
Alternative Names: Mesenchymal stem cells research programme - MorphogenLatest Information Update: 05 May 2003
Price :
$50
*
At a glance
- Originator Morphogen Pharmaceuticals
- Class
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bone disorders
Most Recent Events
- 05 May 2003 No development reported - Preclinical for Bone disorders in USA (unspecified route)
- 17 Aug 2001 The programme is still in active development
- 05 Feb 1998 Preclinical development for Bone disorders in USA (Unknown route)